Femring vs Estring: Which Vaginal Estrogen Ring Is Right for You?
Editorial research, not medical advice. This page is not reviewed by a clinician. Medical and regulatory facts are sourced to the FDA, The Menopause Society, and each product’s prescribing information, and linked inline. The HRT Index may earn a commission from some links, but this page prioritizes FDA label facts, clinical fit, and verified availability over payout.
Femring vs Estring comes down to one thing: local versus systemic estrogen. Estring is a low-dose, local ring for vaginal menopause symptoms — dryness, painful sex, irritation. Femring is a systemicring that also treats hot flashes and night sweats. Pick by your symptoms. And if you have a uterus, Femring usually means adding a progestogen, while Estring usually doesn’t.
Here’s the part almost nobody spells out, and it’s the whole reason these two get confused: “vaginal ring” does not mean “low dose.” One of these rings barely changes the estrogen in your blood. The other raises it about ten times more. We pulled the exact numbers from both FDA labels — because that one difference decides which ring is right for you, what it costs, and what to confirm before you pay for anything.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
Estring vs Femring at a glance
Last verified June 2026. Prices are public signals that change by pharmacy, ZIP code, insurance, and coupon — confirm yours at checkout. Both products are FDA-approved and brand-name only.
| Estring | Femring | |
|---|---|---|
| Type | Local, low-dose vaginal estrogen | Systemic estrogen, delivered by a vaginal ring |
| Active ingredient | Estradiol | Estradiol acetate (turns into estradiol in the body) |
| Estrogen released per day | About 7.5 mcg (0.0075 mg) | 0.05 mg or 0.1 mg (50–100 mcg) |
| FDA-approved to treat | Moderate-to-severe vulvar and vaginal atrophy (dryness, painful sex, irritation) | Moderate-to-severe hot flashes/night sweats plus vulvar and vaginal atrophy |
| Estrogen in your blood | ~7–8 pg/mL — within the untreated post-menopause range | 40.6 pg/mL (0.05 mg) or 76 pg/mL (0.1 mg) — clearly systemic |
| Progestogen if you have a uterus? | Usually not needed (low-dose local) | Generally recommended — systemic estrogen + uterus |
| 2026 FDA boxed warning | Removed Feb 12, 2026 (first batch of 6 products updated) | Systemic estrogen-alone — uterine-cancer warning retained; confirm current label |
| Worn for | 90 days, then replace | 90 days, then replace |
| Doses | One (2 mg ring) | Two (0.05 mg, 0.1 mg) |
| Generic? | No — brand only | No — brand only |
| Maker | Pfizer | Millicent Pharma |
| Cash price per ring (varies) | ~$249–$680 | ~$876–$953 (retail averages climb past $1,000) |
| Maker savings card | Commercial insurance: as little as $25/prescription (limits apply) | Programs vary — verify current terms at femring.com |
| Best fit | Vaginal dryness, painful sex, or irritation only | Hot flashes/night sweats (with or without vaginal symptoms) who want one systemic ring |
| Not your fit if | You have hot flashes or night sweats (it won't treat them) | You only have vaginal symptoms (more estrogen and cost than you need) |
Estring is usually the better conversation if:
- ✓Your main problems are vaginal dryness, painful sex, or irritation after menopause
- ✓You want the lowest estrogen exposure that still fixes the problem
- ✓You are not trying to treat hot flashes or night sweats
Femring is usually the better conversation if:
- ✓You have hot flashes or night sweats and like the idea of one ring replaced every 3 months
- ✓You also have vaginal symptoms, and your clinician agrees systemic estrogen is right for you
- ✓You can sort out your uterus status, progestogen need, and any risk factors first
Neither should be started without a clinician if:
You have unexplained vaginal bleeding, a history of breast or other estrogen-sensitive cancer, blood clots, stroke, heart attack, liver disease, a bleeding disorder, or a possible pregnancy. Both FDA labels list these as reasons to avoid the medicine or get checked first.
Not sure if your symptoms are local-only or whole-body?
That one answer changes everything else on this page. Match your symptoms, your state, and your insurance in The HRT Index’s free Find My HRT Path tool — it’ll flag if your situation should start with an in-person clinician.
Find My HRT Path → match my symptoms before I pay for a consultWhat’s the real difference between Femring and Estring?
Femring and Estring are both 90-day estradiol vaginal rings, but they are not the same kind of treatment. Estring is local vaginal estrogen for vaginal symptoms. Femring is systemic estrogen — it raises estrogen levels through your whole body — and it’s FDA-approved for hot flashes and night sweats as well as vaginal symptoms. The shape is the same. The job is not.
Three definitions the whole decision rides on:
- Local estrogen works mostly where you put it. Very little reaches the rest of your body. Estring is local.
- Systemic estrogen travels through your bloodstream and treats your whole body — which is what you need for hot flashes. Femring is systemic.
- GSM (genitourinary syndrome of menopause) = vaginal dryness, painful sex, irritation, and some urinary changes. VMS (vasomotor symptoms) = hot flashes and night sweats. Estring’s FDA approval is for vulvar and vaginal atrophy — the dryness/painful-sex side of GSM.
The cleanest way to hold it in your head: Estring = local vaginal symptoms. Femring = whole-body menopause symptoms, from a ring.
A real-world caution: double-check which ring you got
Because the names look and sound so similar, it’s worth confirming your prescription and your pharmacy label actually say the ring you and your clinician intended. A swap isn’t a harmless substitution — these two treat different symptoms at very different doses. If you asked about hot flashes and walked out with Estring, you’d be paying for a ring that can’t treat the thing that sent you to the doctor. Read the box. Ask the pharmacist.
Should you choose Estring or Femring for your symptoms?
If your symptoms are only vaginal, Estring belongs in the local-estrogen conversation. If you have hot flashes or night sweats, Femring belongs in the systemic-therapy conversation — alongside patches, gels, sprays, and pills. Match the symptom category first, then pick the product. Getting this order right is what saves you from the wrong ring.
| Your symptoms | The right conversation | Why |
|---|---|---|
| Vaginal dryness, painful sex, or irritation only | Estring (or another local vaginal estrogen) | Estring is FDA-approved for these local symptoms and keeps blood estrogen low |
| Hot flashes, night sweats, sleep wrecked by sweats | Femring (or another systemic estrogen) | Estring won’t touch hot flashes. Femring is FDA-approved for them |
| Both vaginal symptoms and hot flashes | A clinician-guided systemic-vs-combined plan | The real question becomes systemic therapy, possibly with a local add-on, plus uterus and risk review |
Notice what’s not on that list: “whichever ring is stronger.” Stronger isn’t the goal. The right amount of estrogen for your symptoms is the goal. See our full guide to vaginal estrogen vs systemic estrogen for more on how to tell the difference.
Does Estring treat hot flashes or night sweats?
No. Estring’s FDA label describes it as local estrogen therapy for vaginal symptoms. It is not approved for, and is not relied on for, hot flashes or night sweats. If hot flashes are the reason you started searching, Estring is usually the wrong target — you want a systemic option.
This matters before you spend a dollar. Estring can run several hundred dollars for a 90-day ring. Using it hoping it’ll cool down your hot flashes means paying that price for a problem it isn’t built to solve.
Script to bring to your appointment
“My main problem is hot flashes and night sweats, not just vaginal dryness. Is a local ring like Estring enough, or do I need to talk about systemic estrogen?”
Is Femring local estrogen or systemic HRT? How much actually reaches your blood?
Femring is a vaginal ring, but it is systemic hormone therapy — not “Estring but stronger.” The FDA labels show Femring raises the estradiol in your blood far above what Estring does, which is exactly why it can treat hot flashes. The route is vaginal. The treatment category is whole-body.
| Ring | Estradiol in blood (average) | What that means |
|---|---|---|
| Estring | ~7–8 pg/mL (7.8 at week 12) | Within the range seen in untreated post-menopausal women. About 8% of the released dose is absorbed. Essentially local. |
| Femring 0.05 mg | 40.6 pg/mL | Roughly 5× Estring. Clearly systemic. |
| Femring 0.1 mg | 76 pg/mL | Roughly 10× Estring. Clearly systemic. |
Sources: Estring prescribing information, FDA; Femring label, DailyMed.
Read that again, because it’s the heart of the whole decision. Estring barely moves your blood estrogen. Femring at the higher dose puts about ten times more estradiol into your bloodstream.That’s not a small gap. It’s the difference between “treats one spot” and “treats your whole body” — and it’s why the two rings carry different safety conversations.
Why “systemic” changes the decision
- Do you have a uterus? If yes, systemic estrogen generally needs a progestogen to protect the uterine lining.
- Any reason to avoid systemic estrogen? Clot history, certain cancers, and a few other conditions matter more with systemic therapy.
- Is a ring even the best systemic route for you? Patches, gels, sprays, and pills are also systemic. A ring is one option, not the only one — and not always the cheapest.
Do you need progesterone with Femring or Estring if you have a uterus?
With Femring (systemic estrogen), if you have a uterus, a progestogen is generally recommended — a progesterone-type medicine that protects your uterine lining. With low-dose Estring, The Menopause Society’s position is that a progestogen is generally not needed, because so little estrogen reaches the rest of your body. This is one of the biggest practical differences between the two rings.
Femring + a uterus
Femring’s FDA label is clear: when estrogen is prescribed for a post-menopausal woman with a uterus, a progestogen should generally be added. Systemic estrogen with no progestogen (“unopposed” estrogen) raises the risk of uterine (endometrial) cancer, and adding a progestogen has been shown to lower the risk of uterine-lining overgrowth. Your clinician decides the specific progestogen and schedule.
Estring + a uterus
Because Estring keeps blood estrogen near the untreated baseline (~7–8 pg/mL), The Menopause Society states that a progestogen is generally not needed with low-dose vaginal estrogen. Two honest caveats: long-term uterine safety past one year hasn’t been fully studied, and any unexplained vaginal bleeding after menopause needs to be checked, no matter which product you use.
The exact question to ask your clinician
“Because I still have my uterus, does this option need a progestogen to protect my uterine lining — or is it low-dose local therapy that doesn’t?”
If your uterus status changes your options — and it often does — get your consult questions sorted before you book. The HRT Index’s Find My HRT Path tool lines up the right questions for your situation.
Estring, Femring, and a history of breast cancer
Low-dose local vaginal estrogen keeps blood estrogen near the untreated post-menopausal range, so it’s sometimes discussed for stubborn vaginal symptoms after breast cancer — when non-hormonal options aren’t enough, and with your oncologist’s input. Femring is systemic and raises blood estrogen well above that range, so it is not in the low-absorption category. If you have an estrogen-sensitive cancer history, this is a conversation for your oncology team, not a self-serve decision.
The reason comes back to the numbers above. Estring’s whole design goal is to fix local symptoms withoutraising the estrogen circulating in your body. Femring is the opposite — it’s meant to raise it. The Menopause Society notes that safety data in women with breast cancer are limited, and that decisions should weigh your symptoms against your oncologist’s guidance.
If you’ve had breast cancer, a clotting disorder, a stroke, or another serious risk factor, some situations belong with an in-person clinician first — not online care. Check which path fits your history in The HRT Index’s Find My HRT Path tool before you book anything.
Femring vs Estring cost: which is cheaper in 2026?
Estring is generally the cheaper ring. Both are brand-name only with no generic, but public 2026 prices put Estring roughly in the $249–$680 range per 90-day ring, while Femring runs about $876–$953 (retail averages climb past $1,000). Manufacturer savings programs exist but have real limits — and Femring’s terms have changed, so verify them directly. Your true price depends on your plan, pharmacy, ZIP code, and coupon.
| Ring | Public cash/coupon signal | Roughly per month | Where we checked (June 2026) |
|---|---|---|---|
| Estring | As low as ~$249; retail average ~$663–$680 | ~$83–$227 | GoodRx (coupon + retail signal) |
| Estring | ~$572 for one ring | ~$191 | Drugs.com (cash estimate) |
| Femring 0.05 mg | ~$895 for one ring | ~$298 | Drugs.com (cash estimate) |
| Femring 0.1 mg | ~$953 for one ring | ~$318 | Drugs.com (cash estimate) |
| Femring (either dose) | Retail averages above ~$1,000 | ~$300–$370 | GoodRx retail signal |
Cash/coupon and retail signals from GoodRx and Drugs.com, by product and dose, June 2026. These are public estimates, not insurance prices — confirm yours before you fill.
Savings programs — read the fine print
- Estring (Pfizer): Eligible patients with commercial insurance may pay as little as $25 per prescription, with savings up to $360 per fill and $1,440 per year. Cash-pay, Medicare, and Medicaid patients are not eligible.
- Femring (Millicent): The terms have shifted — don’t trust an old “$25” figure. The current Femring Savings Program is built for Medicare patients whose Part D plan doesn’t cover Femring. A separate commercial-insurance card has been offered but the savings amount varies, and as of mid-2026 some pricing databases list no active manufacturer promotion. Check femring.com for the current offer before you count on a number.
The 3-price rule before you fill
- Your insurance copay. Brand-name estrogen is often on a high tier, so coverage doesn’t always mean cheap. Femring frequently needs prior authorization or step therapy.
- The current manufacturer card. Verify today’s terms — they’re not what they were a year ago.
- The cash coupon at your specific pharmacy. Sometimes a GoodRx-style cash price beats your insurance copay.
Want to know whether a clinician can prescribe FDA-approved vaginal estrogen in your state? — they evaluate your symptoms and work with insurance. Paying cash and want a flat-fee path? . (Confirm the exact ring is available during intake — and if you’re still deciding which ring you need, start with the matcher above.)
For a full breakdown, see our dedicated pages on Estring cost without insurance and Femring cost without insurance.
What if cost is the dealbreaker? Cheaper paths by symptom
If the ring’s price stops you, you are not stuck. The cheaper option depends on your symptoms — local-only symptoms have low-cost vaginal alternatives, and hot flashes have low-cost systemic alternatives. Match the symptom first, then the budget.
If your symptoms are vaginal-only (the Estring lane), ask about these local options:
| Local option | Form | Rough public price | Note |
|---|---|---|---|
| Estring | 90-day ring | ~$249–$680/ring | Brand only |
| Yuvafem (generic Vagifem) | Vaginal tablet | Often under ~$100 (8-pack) | Generic; usually far cheaper than the ring |
| Generic estradiol vaginal cream | Cream | Varies; generally below ring cost | Generic available |
| Vaginal DHEA (Intrarosa) | Vaginal insert | Prescription; price varies — ask | Non-estrogen route |
| Ospemifene (Osphena) | Daily pill | Prescription; price varies — ask | Non-estrogen; for painful sex |
If your symptoms are systemic (the Femring lane), ask about these — most are much cheaper than the ring:
| Systemic option | Form | Rough public price | Note |
|---|---|---|---|
| Femring | 90-day ring | ~$876–$953/ring (~$300–$370/mo) | Brand only |
| Generic oral estradiol | Daily pill | ~$10–$30/month | Much cheaper |
| Generic estradiol patch | Skin patch | ~$30–$80/month | Often cheaper; patches avoid the liver's first pass |
See also: cheapest vaginal estrogen without insurance and ospemifene vs vaginal estrogen.
What if insurance or the pharmacy swaps one ring for the other?
Do not treat a switch from Femring to Estring (or the reverse) as a free, equal swap. They have different FDA-approved uses at very different doses, so the right substitute depends entirely on whether your prescription is for local vaginal symptoms or whole-body menopause symptoms. A denial or substitution is a question to ask, not an answer to accept.
To your insurance
“My clinician prescribed [Femring/Estring] for [hot flashes and night sweats / vaginal symptoms]. Is this denied because it’s non-formulary, because it needs prior authorization, because step therapy is required, or because the diagnosis doesn’t match the rule?”
To your clinician’s office
“Can you confirm whether my prescription is meant as local vaginal estrogen or systemic estrogen therapy? My pharmacy mentioned the other ring, and I want the substitute to match my symptoms.”
The thing to avoid: grabbing a cheaper ring just because it’s cheaper. If you need hot flash relief and accept Estring to save money, you’ve saved nothing — it can’t treat hot flashes.
What the 2026 FDA label changes mean for these rings
In early 2026, the FDA removed the prominent “boxed warning” from low-dose local vaginal estrogen — and Estring was in the first batch approved on February 12, 2026. The risk statements removed were for cardiovascular disease, breast cancer, and probable dementia. Femring is a systemic estrogen-alone product, so it keeps the uterine-cancer warning even as other warning language is removed across hormone therapy. The change reflects strong evidence that local and systemic estrogen carry very different risks — not that hormones are risk-free.
What actually happened
- November 2025: The FDA began revising labels, separating local and systemic estrogen risk language.
- February 12, 2026: FDA approved the first six updated products, with cardiovascular, breast cancer, and dementia statements removed from the boxed warning. Estring was one of the six.
- Femring: Keeps the uterine-cancer warning (systemic estrogen-alone). Femring wasn’t in that first batch of six — confirm Femring’s current warning language on the latest prescribing information when you’re deciding.
The Menopause Society backed removing the boxed warning on low-dose vaginal estrogen, calling it a safe and effective treatment for a problem most menopausal women face — while noting that systemic estrogen still carries real risks that should be reviewed person by person. “Warning removed” does not mean “right for everyone” — the cautions above still stand.
What side effects should you watch for with each ring?
Both rings can cause local effects like vaginal discharge, irritation, or yeast infection, plus headache. Because Femring is systemic, it more often causes breast tenderness and can cause vaginal bleeding — and any unexpected bleeding should be checked promptly.
| Effect | Estring (local) | Femring (systemic) | Why it matters |
|---|---|---|---|
| Vaginal discharge, irritation, or yeast | Possible | Yeast in ~6–11% of users | Local effects come with any vaginal ring |
| Headache | Possible | ~7–10% | Common, usually mild |
| Breast tenderness | Less likely (low absorption) | More common (~6–11%) | A systemic estrogen effect |
| Vaginal bleeding or spotting | Less likely | Can occur (~8–10%); any unexpected bleeding → get checked | More estrogen reaching the uterus |
| Serious risks (clot, stroke, etc.) | Lower (very low absorption) | Systemic-estrogen risks apply | The core local-vs-systemic difference |
Call your clinician right away for:
Unusual vaginal bleeding, a new breast lump, chest pain, shortness of breath, leg pain or swelling, sudden vision changes, severe headache, or signs of toxic shock syndrome (fever, nausea, vomiting, diarrhea, muscle aches, dizziness, or a sunburn-like rash). These are uncommon, but they’re worth knowing.
Can you use Femring and Estring together?
That’s a clinician-only decision, not a default combination.Because Femring is systemic and Estring is local, the real question isn’t “can two rings fit?” — it’s whether adding local therapy on top of systemic therapy makes sense for your symptoms, your total estrogen exposure, and your uterus and risk profile. Don’t stack estrogen products on your own.
| Your situation | Question to ask | Likely direction |
|---|---|---|
| Hot flashes controlled on systemic therapy, but vaginal dryness lingers | "Would adding a low-dose local vaginal estrogen help my remaining symptoms?" | Possibly systemic + a local add-on |
| Only vaginal or local symptoms | "Is local therapy alone enough for me?" | Local only |
| Pharmacy gave you both, or you're unsure what you have | "Which ring did you intend, and do I need both?" | Confirm before using anything |
| You want one product to cover everything | "Is systemic therapy alone enough, or do I need a local add-on too?" | Clinician-guided |
Will the ring stay in place — and what about sex and prolapse?
Both rings are designed for extended vaginal wear, and their labels say you shouldn’t be able to feel the ring when it’s positioned correctly, and it shouldn’t interfere with sex. But fit and comfort vary, and certain conditions make a ring less suitable.
- Feeling it.Positioned far enough up, you shouldn't feel either ring. If you do, it usually isn't in far enough — push it gently higher.
- Sex.Both labels say the ring shouldn't interfere with intercourse, and you can leave it in. If it comes out, rinse it in warm water and reinsert.
- Slippage.Hard straining during a bowel movement or weak vaginal muscles can move a ring down or out. If yours comes out often, tell your clinician — it may not be the right fit.
- Prolapse and similar conditions.Femring's label specifically notes it may not suit women with a narrow vagina, vaginal stenosis, vaginal infection, cervical prolapse, or a rectocele/cystocele. Raise it before starting.
Where can you get Femring or Estring prescribed online?
Some menopause-focused telehealth providers can evaluate your symptoms and prescribe FDA-approved estrogen, but you should confirm that the provider can send the exact ring to your pharmacy — and whether online care fits your history — before you pay for a consult.Don’t assume any telehealth service stocks Femring or Estring specifically until it’s confirmed.
| Provider | What it publicly states | What we verified | Confirm before you commit |
|---|---|---|---|
| Midi Health | Virtual menopause and midlife care in all 50 states; insurance covers eligible virtual visits and prescriptions | All-50-states and insurance claims appear on Midi’s public site | Whether they’ll prescribe your exact ring (Estring/Femring) and your specific coverage — ask at intake |
| Sesame Care | Online menopause care on a flat cash-pay basis; prescriptions sent to your pharmacy; medication billed separately | Cash model and pharmacy-sent prescriptions appear on Sesame’s public site | Exact Estring/Femring prescribing and total medication cost — ask at intake |
Before you pay, ask the provider:
- ✓Can you prescribe FDA-approved estradiol vaginal rings to my pharmacy?
- ✓Can you prescribe Estring? Can you prescribe Femring?
- ✓Do you manage systemic estrogen if I have a uterus, including a progestogen when recommended?
- ✓Do you take insurance, give a superbill, or cash-pay only?
- ✓Can you help with prior authorization?
- ✓Which states do you serve?
Also see: how to get an Estring prescription online, how to get a Femring prescription online, and best online providers for vaginal estrogen.
What should you ask your clinician before choosing Femring or Estring?
Bring the whole decision down to a handful of questions: Are my symptoms local or whole-body? Do I have a uterus? Are there reasons to avoid systemic estrogen? What will insurance actually cover? Can this provider prescribe the exact product I need?
The checklist — screenshot or screenshot-save this:
- Are my symptoms local-only, whole-body, or a mix?
- Is this option local vaginal estrogen or systemic estrogen therapy?
- If I have a uterus, do I need a progestogen with it?
- Are there reasons I should avoid systemic estrogen?
- Is there a lower-cost option that treats the same symptoms?
- Will my insurance cover this exact product?
- What should I do if the pharmacy suggests the other ring?
How The HRT Index verified this comparison
We built this comparison from current FDA and DailyMed prescribing information for both rings, The Menopause Society’s guidance, the FDA’s 2025–2026 labeling actions, manufacturer savings terms, and public pharmacy price signals. Our editorial conclusions are judgments based on those verified facts, not on which link pays us more. Where a number can change, we labeled it and dated it.
Last verified: June 2026
- –Estring: FDA-approved for moderate-to-severe vulvar and vaginal atrophy; ~7.5 mcg/day release; blood estradiol ~7–8 pg/mL; ~8% systemic absorption; boxed warning removed Feb 12, 2026; brand-only, made by Pfizer.
- –Femring: FDA-approved for hot flashes/night sweats and vaginal atrophy; 0.05 or 0.1 mg/day; blood estradiol 40.6 and 76 pg/mL; progestogen generally recommended with a uterus; systemic estrogen-alone warning language; brand-only, made by Millicent Pharma.
- –The progestogen difference, the breast-cancer/absorption point, and the 90-day wear schedule for both.
- –Public 2026 price signals from GoodRx and Drugs.com, and the savings-program terms on the manufacturers' pages.
What still needs your verification
- Your exact insurance copay and any prior-authorization or step-therapy rules
- Whether your pharmacy has the ring in stock
- The current Femring savings-program terms (they’ve changed) and your eligibility
- Whether a specific online provider can prescribe the exact ring to you
- Whether online care is appropriate for your personal risk history
Frequently asked questions
Is Femring the same as Estring?
No. Both are estradiol vaginal rings worn for 90 days, but Estring is low-dose local estrogen for vaginal symptoms, while Femring is systemic estrogen also FDA-approved for hot flashes and night sweats. They treat different problems at very different doses.
Which is stronger, Femring or Estring?
Femring puts far more estrogen into your blood — about 40.6 pg/mL at the low dose and 76 pg/mL at the high dose, versus roughly 7 to 8 pg/mL for Estring. But stronger is not the right question. The better question is whether you need local vaginal therapy or whole-body therapy.
Does Estring help with hot flashes?
No. Estring is local estrogen for vaginal symptoms and should not be relied on for hot flashes or night sweats. For those, you would look at a systemic option like Femring, a patch, or a gel.
Does Femring help vaginal dryness?
Yes. Femring is FDA-approved for vulvar and vaginal atrophy as well as hot flashes. But it is a systemic estrogen, so it should be evaluated as whole-body therapy, not just a local ring.
Do you need progesterone with Femring?
If you have a uterus, a progestogen is generally recommended. Femring's label says one should generally be added to systemic estrogen to lower uterine cancer risk. A woman without a uterus generally does not need one. Your clinician decides the specific progestogen and schedule.
Do you need progesterone with Estring?
Usually not. The Menopause Society's position is that a progestogen is generally not needed with low-dose vaginal estrogen, because so little estrogen reaches the body. Long-term uterine data past one year is limited, and any unexplained bleeding still needs to be checked.
Which costs more, Femring or Estring?
Femring costs more. Public 2026 prices put Femring around $876 to $953 per 90-day ring with retail averages climbing past $1,000, while Estring runs roughly $249 to $680. Your real cost depends on your plan, pharmacy, ZIP code, and coupon, and both are brand-name only.
Is there a generic for Estring or Femring?
No. As of 2026, both are brand-name only with no generic, which is the main reason they are pricey. If cost is the issue and your symptoms are local-only, a cheaper option like a generic vaginal estradiol tablet may be worth asking about.
Can my pharmacy substitute Estring for Femring?
Do not treat a substitution as equal without your clinician confirming it. The two have different FDA-approved uses, so the right substitute depends on whether your prescription is for local vaginal symptoms or whole-body menopause symptoms.
Which should I ask for if I only have vaginal dryness?
If your symptoms are local-only, Estring belongs in the local vaginal estrogen conversation — and so might a cheaper cream, tablet, or insert. Your clinician can help you choose based on your history and budget.
Which should I ask for if I have hot flashes and vaginal dryness?
Ask about systemic options first, and whether you also need local therapy. Femring is one systemic ring choice, but patches, gels, sprays, and pills belong in that conversation too — and may cost less.
Still not sure which ring — or whether online care — is right for you?
Take The HRT Index’s free Find My HRT Path matching quiz. In about 90 seconds, it matches your symptoms, your state, and your situation to the right next step — and flags when you should start with an in-person clinician.
Find My HRT Path → take the free quizAlso on The HRT Index
- Estring cost without insurance (2026) — every verified way to pay less
- Femring cost without insurance (2026) — real prices and cheaper alternatives
- How to get an Estring prescription online — routes, cost, and who to ask
- How to get a Femring prescription online — routes, cost, and coverage
- Estradiol vaginal ring online — Estring vs Femring and how to get one prescribed
- Vaginal estrogen guide — all forms: rings, tablets, creams, and inserts compared
- Vaginal estrogen vs systemic estrogen — how to tell which one you actually need
- How to use vaginal estrogen cream — if you want a non-ring local option
Sources
- FDA, Estring (estradiol vaginal system) Prescribing Information (2026) — indication, release rate, serum estradiol (~7.8 pg/mL), ~8% systemic absorption
- DailyMed / FDA, Femring (estradiol acetate vaginal ring) Prescribing Information — doses, serum estradiol (40.6 and 76 pg/mL), vasomotor + vaginal indications, progestogen-with-uterus language, contraindications
- FDA, FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, Feb 12, 2026 — first six products (including Estring); cardiovascular, breast cancer, and dementia statements removed
- FDA, FDA Requests Labeling Changes for Menopausal Hormone Therapies, and HHS Fact Sheet, Nov 10, 2025 — endometrial-cancer warning retained for systemic estrogen-alone products
- The Menopause Society — statement on the FDA hormone therapy announcement (Nov 2025) and 2022 Hormone Therapy Position Statement: low-dose vaginal estrogen safety, progestogen guidance, GSM treatment options, breast cancer considerations
- GoodRx — Estring price page
- Drugs.com — Estring price guide
- Drugs.com — Femring price guide